These data indicate that PJA1 promotes the ubiquitination and proteasomal degradation of p-SMAD3, resulting in reduced activity of the TGF-β/SMAD3/SPTBN1 tumor-suppressing pathway in HCC cells (Figure 1). This evidence concerns the gene PJA1 and hepatocellular carcinoma.